SCHEMBL30830815

SCHEMBL30830815

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCC(Oc4ccc(C5CCC(=O)NC5=O)cc4F)CC3)cc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 10/20 0.48
▸ BRD9 Q9H8M2 3/20 0.48
▸ BRD1 O95696 1/20 0.48
▸ ACHE P22303 1/20 0.48
▸ BRPF1 P55201 1/20 0.48
▸ BPTF Q12830 1/20 0.48
▸ KAT2A Q92830 1/20 0.48
▸ BRD7 Q9NPI1 1/20 0.48
▸ BAZ2B Q9UIF8 1/20 0.48
▸ BRPF3 Q9ULD4 1/20 0.48
▸ GPR6 P46095 3/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830729 0.89 KAT2B (0.52) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830570 0.89 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830684 0.88 KAT2B (0.56) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830530 0.88 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830658 0.87 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830652 0.86 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830638 0.86 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830768 0.85 KAT2B (0.58) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830823 0.85 KAT2B (0.58) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830614 0.84 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback